Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAngioDynamics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.16 | -$0.15 | -$0.16 |
| Q2 2024 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q3 2024 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q4 2024 | 3 | -$0.12 | -$0.10 | -$0.11 |
| Q1 2025 | 3 | -$0.11 | -$0.11 | -$0.11 |
| Q2 2025 | 2 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2025 | 2 | -$0.10 | -$0.09 | -$0.10 |
| Q4 2025 | 2 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2026 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q2 2026 | 1 | -$0.02 | -$0.01 | -$0.02 |
AngioDynamics, Inc. Earnings Date And Information
AngioDynamics, Inc. last posted its earnings results on Thursday, October 3rd, 2024. The company reported $-0.11 earnings per share for the quarter, topping analysts' consensus estimates of $-0.15 by $0.04. The company had revenue of 67.49 M for the quarter and had revenue of 303.91 M for the year. AngioDynamics, Inc. has generated $-5 earnings per share over the last year ($-4.59 diluted earnings per share) and currently has a price-to-earnings ratio of -1.49. AngioDynamics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 3rd, 2025 based on prior year's report dates.
AngioDynamics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/03/2024 | Q1 2025 | -$0.15 | -$0.31 | -0.16 | $67.93 M | $67.49 M |
| 07/25/2024 | Q4 2024 | -$0.33 | $70.86 M | $70.98 M | ||
| 04/09/2024 | Q3 2024 | -$4.67 | $75.18 M | |||
| 01/08/2024 | Q2 2024 | -$0.72 | $79.07 M | |||
| 10/05/2023 | Q1 2024 | $1.15 | $77.70 M | $78.68 M | ||
| 08/03/2023 | Q4 2023 | -$0.54 | $90.74 M | $91.07 M | ||
| 03/31/2023 | Q3 2023 | -$0.24 | $80.71 M | |||
| 01/06/2023 | Q2 2023 | -$0.21 | $85.43 M | |||
| 10/11/2022 | Q1 2023 | -$0.33 | $83.43 M | $81.54 M | ||
| 07/22/2022 | Q4 2022 | -$0.16 | $82.92 M | $87.00 M | ||
| 04/07/2022 | Q3 2022 | $0.01 | -$0.13 | -0.14 | $73.97 M | |
| 01/07/2022 | Q2 2022 | -$0.21 | $78.28 M | |||
| 09/30/2021 | Q1 2022 | -$0.05 | -$0.18 | -0.13 | $71.30 M | $76.97 M |
| 07/27/2021 | Q4 2021 | -$0.51 | $72.67 M | $76.84 M | ||
| 03/31/2021 | Q3 2021 | -$0.09 | $71.18 M | |||
| 01/08/2021 | Q2 2021 | -$0.11 | $72.77 M | |||
| 10/07/2020 | Q1 2021 | -$0.11 | $65.11 M | $70.22 M | ||
| 08/10/2020 | Q4 2020 | -$4.10 | $62.86 M | $58.33 M | ||
| 04/08/2020 | Q3 2020 | -$0.15 | $69.78 M | |||
| 01/08/2020 | Q2 2020 | -$0.07 | $70.00 M |
AngioDynamics, Inc. Earnings: FAQ's
When is AngioDynamics, Inc.'s earnings date?
AngioDynamics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 3rd, 2025 based off last year's report dates.
Did AngioDynamics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, AngioDynamics, Inc. (:ANGO) reported $-0.11 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.15 by $0.04.
How can I listen to AngioDynamics, Inc.'s earnings conference
call?
The conference call for AngioDynamics, Inc.'s latest earnings report can be listened to online.
How can I read AngioDynamics, Inc.'s conference call transcript?
The conference call transcript for AngioDynamics, Inc.'s latest earnings report can be read online.
How much revenue does AngioDynamics, Inc. generate each year?
AngioDynamics, Inc. (:ANGO) has a recorded annual revenue of $303.91 M.
How much profit does AngioDynamics, Inc. generate each year?
AngioDynamics, Inc. (:ANGO) has a recorded net income of $303.91 M. AngioDynamics, Inc. has generated $-4.59 earnings per share over the last four quarters.
What is AngioDynamics, Inc.'s price-to-earnings ratio?
AngioDynamics, Inc. (:ANGO) has a price-to-earnings ratio of -1.49 and price/earnings-to-growth ratio is 0.05.